The effect of in vivo interferon-gamma on the distribution of LFA-1 and ICAM-1 in normal human skin.
Lymphocyte function associated antigen 1 (LFA-1) and its ligand intercellular adhesion molecule 1 (ICAM-1) are cell surface adhesion molecules important in many lymphocyte-mediated responses. Recent in vitro studies have demonstrated that the cytokine interferon-gamma (IFN-gamma) can induce ICAM-1 expression by keratinocytes, and that lymphocytes adhere to IFN-gamma treated keratinocytes. In view of the importance of keratinocyte/lymphocyte interactions in the pathogenesis of cutaneous disease, we have examined the effects of in vivo IFN-gamma on cutaneous expression of LFA-1 and ICAM-1. Fourteen volunteers received intradermal IFN-gamma (dose: 1 or 10 micrograms) daily for 3 d. Biopsy was obtained on day 6. Cryostat sections were stained by the peroxidase antiperoxidase technique employing murine monoclonal antibodies to CD11, CD18, and ICAM-1. IFN-gamma intensified ICAM-1 expression by dermal endothelial cells and induced keratinocyte expression of ICAM-1. Furthermore, after administration of 10 micrograms of IFN-gamma LFA-1 positive (LFA + ve) lymphocytes were observed along the basement membrane zone closely related to ICAM-1 + ve basal keratinocytes and also surrounding dermal endothelium. Exposure to IFN-gamma induced expression of both CD11a and CD18 antigens on epidermal Langerhans cells. These studies suggest that the distribution of adherence molecules expression within cutaneous tissue in vivo is modulated by IFN-gamma, and that these alterations may be important in interactions involving cutaneous immunocompetent cells.
Barker
J N
JN
Laboratory of Applied Dermatopathology, United Medical and Dental Schools (Guy's Campus), London, United Kingdom.
Allen
M H
MH
MacDonald
D M
DM
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000943:Antigens, Differentiation / Q000032:analysis*; D000954:Antigens, Surface / Q000032:analysis*; D002448:Cell Adhesion; D015815:Cell Adhesion Molecules; D000078404:Epidermal Cells; D006801:Humans; D007150:Immunohistochemistry; D007371:Interferon-gamma / Q000008:administration & dosage / Q000494:pharmacology*; D007633:Keratins / Q000276:immunology; D007801:Langerhans Cells / Q000276:immunology; D016169:Lymphocyte Function-Associated Antigen-1; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D011994:Recombinant Proteins; D012016:Reference Values; D012867:Skin / Q000166:cytology / Q000276:immunology*
D000943:Antigens, Differentiation; D000954:Antigens, Surface; D015815:Cell Adhesion Molecules; D016169:Lymphocyte Function-Associated Antigen-1; D011994:Recombinant Proteins; D007633:Keratins; D007371:Interferon-gamma